Fisher & Paykel Healthcare Corporation Limited Overview
Pro stress-test →Fisher & Paykel Healthcare specializes in designing, manufacturing, and marketing medical device products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea, with products divided into hospital and homecare segments. The company's products are sold in more than 120 countries worldwide.
Strategic Profile
Pro stress-test →The company invested $226.9 million in R&D during 2025 and expanded rollout of key products like F&P Airvo™ 3 and F&P 950™ System in the US market. Gross margin for FY 2026 is expected to improve by 50 basis points despite a 75 bps tariff impact, with operating expense growth remaining below long-term revenue growth aspirations.
Competitive Landscape
Pro stress-test →Fisher & Paykel competes in respiratory care, surgical devices, and sleep apnea treatment markets. Key competitors include ResMed (CPAP/ventilation), Philips Healthcare (respiratory care), Medtronic (surgical/ventilation), and GE Healthcare in hospital respiratory devices. FPH holds a strong niche position in high-flow nasal therapy and homecare respiratory solutions.
Industry Context
Fisher & Paykel Healthcare Corporation Limited operates in Medical Devices - Respiratory Care & Home Healthcare Equipment.
Key facts
Founded: 1934 · Headquarters: Auckland, New Zealand · Employees: 7412 · Revenue: $1.74B · Market cap: $21.5B